Recently, many of the federally filed lawsuits have been consolidated into a multidistrict litigation that is based out of the eastern district of Louisiana. Judge Eldon Fallon is presiding over the multidistrict litigation (MDL). He has been working in the Eastern District of Louisiana since May 10, 1995.
At this point, more than 400 lawsuits have been transferred to the Louisiana MDL. There is also a mass tort group in Philadelphia, PA where more than 100 lawsuits are currently filed.
Xarelto Lawsuits Filed in Multidistrict Litigation
Individuals who suffered from an injury as a result of taking Xarelto have been filing lawsuits against the drug. These individuals have experienced injuries such as excessive blood clots or severe internal bleeding. Because of the severe injuries that Xarelto allegedly causes, there have been many instances where patients who took Xarelto die as a result of the serious side effects. The estate and family of the deceased have the right to file a wrongful death lawsuit against the manufacturers of Xarelto.
Although they often get mixed up, an MDL is very different from a class action lawsuit. There is currently no class action lawsuit filed against Bayer AG or Johnson&Johnson concerning Xarelto and internal bleeding. Because of the severity of the injuries that Xarelto is alleged to cause and the variety of injuries among the cases, a class action lawsuit is not appropriate for this type of legal action, since a class action lawsuit means that the verdict will be the same for every party involved. An MDL allows for each case to be heard individually and verdicts to be decided on a case to case basis.
A multidistrict litigation requires that all of the lawsuits filed in it make similar allegations against Xarelto’s manufacturers. Most lawsuits filed allege that Xarelto caused uncontrollable internal bleeding which resulted in serious injury of the plaintiff or the death of a loved one.
What Will a Xarelto Lawsuit Settle for?
While it is too early to predict what the Xarelto lawsuits will settle for, previous lawsuits may give us an idea. In May 2014, there were lawsuits brought against a blood thinner similar to Xarelto, Pradaxa. Their manufacturers, Boehringer Ingelheim, settled 4,000 lawsuits concerning Pradaxa for $650 million.
“When one takes into consideration the incidence of internal bleeding among Xarelto users, we can expect that thousands of lawsuits will eventually be filed,” experienced Xarelto attorney Marc Goldich said.
For any questions regarding this press release or the pending Xarelto litigation, please contact Marc Goldich at (866) 425-8902.